The frontier
Each curve is one brand's qualified-starts response to ad spend (diminishing returns). The marker on each is where this allocation sits. Steeper marker = the next dollar buys more there.
Move the $247.4M (sliders optional: the scenarios do the work)
Your analytics team holds the real per-brand spend, so a pure cost-per-start ranking is something they can already pull. What's structurally hard from inside the org chart is a recommendation that's allowed to conclude "shift spend out of the brand we grew fastest," and one drawn inside the regulatory box rather than around it. A pure-ROI optimizer says pour everything into the cheapest funnel; the rules say you can't, because which students you recruit carries a 90/10 and Gainful-Employment dimension, and every earnings claim in the creative is FTC-substantiated. This tool prices that gap: it shows the unconstrained optimum, then shows how many starts the constraints actually cost, so the conversation is about the real trade-off, not a fantasy one.
- Curve shape: diminishing-returns (logarithmic) response of qualified starts to spend, the standard media-saturation shape. Synthetic, calibrated so each brand's relative efficiency matches the public signal: Walden's online-grad funnel competes on auction-priced keywords (against WGU, SNHU, Capella), so its marginal cost-per-start runs higher; Chamberlain's nursing demand is pulled by a documented workforce shortage, so its early dollars convert cheaper.
- The Q1 FY26 anchor: management said Chamberlain "underperformed in local marketing effectiveness" and funnel conversion "fell below benchmarks" while Walden grew 13.6%. That's a real, public divergence in marketing physics; the curves reflect it, they don't invent it.
- 90/10 constraint: proprietary institutions may draw no more than 90% of revenue from federal Title IV funds; the constraint caps how far spend can tilt toward the most aid-dependent funnel.
- GE constraint: programs near a Gainful-Employment debt-to-earnings line can't be aggressively marketed; the GE-safe regime freezes spend on the flagged slice.
What this is not: these are not Covista's real response curves: the company discloses neither per-brand spend nor cost-per-start. The shapes are synthetic and labelled. The method (an independent, compliance-aware frontier) is the deliverable; calibrating it to your real curves is what the engagement scopes.
Sources & method
Public anchors
- Total advertising FY25 $247.4M (13.8% of $1,788.3M revenue); FY24 $227.9M, FY23 $219.4M: 10-K accounting-policies note. FY2025 10-K
- Segment revenue / margin FY25: Chamberlain $725.8M / 20.9%, Walden $693.4M / 25.7%, Med & Vet $369.1M / 18.6% (10-K segment data).
- Q1 FY26 (Sept-2025 quarter): Walden enrollment +13.6%; Chamberlain +2.2% with margin down 240 bps; CEO on the "local marketing effectiveness" and "funnel conversion" miss: Q1 FY26 earnings call.
- 90/10 final rule (34 CFR 668.28): FederalRegister.gov. Gainful Employment / FVT (2023): FederalRegister.gov. FTC deceptive-earnings posture: ftc.gov.
- Nursing demand: ~189,100 RN openings/yr, 40% NP growth: BLS OOH; 80,162 qualified applications turned away 2024: AACN.